Search - tctmd.com

Displaying 441 - 460 of 749

Sort: Relevancy | Date

News Daily News

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

January 22, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

News Daily News

Andamio Bioabsorbible Funciona Bien en Pacientes STEMI Seleccionados

January 22, 2014

News Daily News

Los Valores FFR en Lesiones Intermedias se ven Influidos por una Respuesta Exagerada a la Adenosina

January 15, 2014

News Daily News

La Comisurotomía Mitral Percutánea es Efectiva incluso en Válvulas Calcificadas

January 15, 2014

News Daily News

FFR Values for Intermediate Lesions Affected by Exaggerated Adenosine Response

January 15, 2014

News Daily News

Grupos Subrayan Cuestiones Importantes para Divulgar las Terapias Transcatéter de la Válvula Mitral

December 02, 2013

News Daily News

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

December 02, 2013

Presentation

Mitraclip Tips and Tricks for Excellence

Presenter: Francesco Maisano

December 01, 2013

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Industry News

Alvimedica merges with CID, Italy's leading high tech company specialized in cardiology

November 19, 2013

News Conference News TCT 2013

Regadenoson Shows Promise in Measuring Fractional Flow Reserve

November 07, 2013

News Conference News TCT 2013

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

October 31, 2013

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

October 31, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

News Industry News

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

October 31, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Are Regulatory Approval Clinical Trials Too Complex and Too Costly for New Devices and New Indications? EXCEL and BVS Experience.

Presenter: Charles Simonton

October 30, 2013

News Conference News TCT 2013

Richard Karl Myler, MD: He Never Met a Stranger

October 30, 2013

Advertisement

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

Bioresorbable Scaffold Performs Well in Select STEMI Patients

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Andamio Bioabsorbible Funciona Bien en Pacientes STEMI Seleccionados

Los Valores FFR en Lesiones Intermedias se ven Influidos por una Respuesta Exagerada a la Adenosina

La Comisurotomía Mitral Percutánea es Efectiva incluso en Válvulas Calcificadas

FFR Values for Intermediate Lesions Affected by Exaggerated Adenosine Response

Grupos Subrayan Cuestiones Importantes para Divulgar las Terapias Transcatéter de la Válvula Mitral

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

Mitraclip Tips and Tricks for Excellence

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Alvimedica merges with CID, Italy's leading high tech company specialized in cardiology

Regadenoson Shows Promise in Measuring Fractional Flow Reserve

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

Innovation in Intervention: Perspectives from Industry

Are Regulatory Approval Clinical Trials Too Complex and Too Costly for New Devices and New Indications? EXCEL and BVS Experience.

Richard Karl Myler, MD: He Never Met a Stranger

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content